6:12 PM
 | 
Feb 13, 2013
 |  BC Extra  |  Politics & Policy

CMS to assess genetic tests for cancer diagnosis

CMS's Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) will meet on May 1 to discuss technology assessments for two types of genetic tests for cancer diagnosis. The committee will discuss the evidence for DNA- or RNA-based tests...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >